NVDA catalysts
Catalysts and events linked to NVDA, newest first.
Do these developments change your position?
Review NVDA alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
See today's live cards
19 live catalysts on NVDA are in Desk now. Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.
DateCardAvg 5d
- 2026-09-27Morgan Stanley Projects $1.4T in Hyperscaler Data Center AI Capex by 2028MSFT NVDA VRT+2.10%
- 2026-09-27Magnificent Seven ETF Hits Record $72.20 Led by Hardware and AI OutperformanceMAGS MSFT NVDA+1.38%
- 2026-09-27Microsoft Q2 Shows 43% Azure Expansion Alongside $678 Billion AI BacklogMSFT NVDA TSM+3.04%
- 2026-09-27Micron Fiscal Q4 Setup Focuses on HBM Demand and Memory Cycle LongevityAMD MU NVDA-0.05%
- 2026-09-27Magnificent Seven ETF Reaches New Record High of $72.20 on NVDA and AAPL StrengthMAGS MSFT NVDA+1.38%
- 2026-09-27MAGS ETF reaches record $72.20 level amid widening mega-cap return dispersionMAGS NVDA TSLA+1.16%
- 2026-09-26AMD Enters $1T Market Cap Club on AI Accelerator Deal PipelineAMD NVDA+2.24%
- 2026-09-25Pfizer and NVIDIA Commit $80M Joint Venture to AI Vaccine Adjuvant DiscoveryDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA invest $80M in CytoReason JV as vaccine AI funding tops $140MDNA NVDA+3.95%
- 2026-09-25Pfizer and Nvidia deploy $80M joint investment into CytoReason AI platformNVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Form $80M AI Venture as Vaccine Discovery Investments Top $140MNVDA PFE+3.95%
- 2026-09-25Pfizer and Nvidia Back $80M AI Computational Immunology VentureNVDA PFE+3.95%
- 2026-09-25TSMC Advances $265B Arizona Manufacturing Buildout Across Advanced Node FabsNVDA+3.95%
- 2026-09-25Pfizer and Nvidia deploy $80M joint investment into CytoReason AI platformNVDA PFE+3.95%
- 2026-09-25Pfizer and Nvidia Back $80M AI Computational Immunology VentureNVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA invest $80M in CytoReason JV as vaccine AI funding tops $140MDNA NVDA+3.95%
- 2026-09-25Pfizer and NVIDIA Commit $80M Joint Venture to AI Vaccine Adjuvant DiscoveryDNA NVDA PFE+3.95%
- 2026-09-25TSMC Advances $265B Arizona Manufacturing Buildout Across Advanced Node FabsNVDA+3.95%
- 2026-09-25Pfizer and NVIDIA Form $80M AI Venture as Vaccine Discovery Investments Top $140MDNA NVDA PFE+3.95%
- 2026-09-25TSMC Directs $265B to Arizona Facilities Amid 72.5% Fabrication ShareNVDA+3.95%
- 2026-09-25TSMC Directs $265B to Arizona Facilities Amid 72.5% Fabrication ShareNVDA TSM+4.44%
- 2026-09-25Pfizer and NVIDIA Form $80M AI Venture as Vaccine Discovery Investments Top $140MDNA NVDA PFE+3.95%
- 2026-09-25TSMC Directs $265B to Arizona Facilities Amid 72.5% Fabrication ShareNVDA TSM+4.44%
- 2026-09-25Oracle declares force majeure on New Mexico data center amid power supply shortagesMSFT NVDA ORCL+1.06%
- 2026-09-25TSMC maintains 72.5% fabrication share with $265B Arizona capex pipelineAMD NVDA TSM+3.13%
- 2026-09-25Pfizer and NVIDIA Form $80M Joint Venture in AI Biopharma Platform CytoReasonDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and Nvidia deploy $80M joint investment into CytoReason AI platformNVDA PFE+3.95%
- 2026-09-25Google to launch Project Suncatcher solar-powered orbital TPU test satellite on Oct 1GOOGL NVDA+3.95%
- 2026-09-25TSMC Advances $265B Arizona Manufacturing Buildout Across Advanced Node FabsNVDA TSM+4.44%
- 2026-09-25Google schedules Project Suncatcher solar TPU satellite launch for October 1GOOGL NVDA+3.95%
- 2026-09-25TSMC advances $265B Arizona capex footprint holding 72.5% fabrication shareNVDA TSM+4.44%
- 2026-09-25Alebex Ranks 8th in Global Speech-to-Text Benchmark, Surpassing Big Tech ModelsGOOGL MSFT NVDA+2.10%
- 2026-09-25Pfizer and Nvidia Form $80M CytoReason AI Drug Discovery JVDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Commit $80M Joint Venture to AI Vaccine Adjuvant DiscoveryDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Back $80M CytoReason Venture for AI Vaccine Adjuvant DiscoveryNVDA PFE+3.95%
- 2026-09-25Pfizer and Nvidia Back $80M AI Computational Immunology VentureNVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA invest $80M in CytoReason JV as vaccine AI funding tops $140MDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Form $80M Joint Venture in AI-Driven Vaccine DiscoveryDNA NVDA PFE+3.95%
- 2026-09-25Pfizer and NVIDIA Form $80M CytoReason Venture as Vaccine AI R&D ExpandsDNA NVDA PFE+3.95%
- 2026-09-24Zacks: S&P 500 Q3 earnings projected +23.9% YoY; Tech +41.9%AMD NVDA+0.33%
- 2026-09-24Meta Muse adoption: 2.8M downloads, 642k daily users and major partner integrationsMETA NVDA-1.92%
- 2026-09-24Ark buys Nvidia as Zacks sees Tech Q3 EPS +41.9% vs S&P +23.9% — NVDA AI multiple re-rateNVDA+2.80%
- 2026-09-24Ark buys Nvidia as Tech Q3 EPS seen +41.9% vs S&P +23.9% — NVDA AI earnings re-rateNVDA+2.80%
- 2026-09-24Ark buys NVDA as Tech Q3 EPS is seen +41.9% vs S&P +23.9% — AI mega-cap flow re-rateNVDA+2.80%
- 2026-09-24Zacks: S&P 500 Q3 earnings projected +23.9% YoY; Tech +41.9%AMD NVDA+0.33%
- 2026-09-24Meta Expands AI Hardware and Deploys Muse Enterprise AgentNVDA SHOP+2.80%
- 2026-09-24Meta Muse adoption: 2.8M downloads, 642k daily users and major partner integrationsMETA NVDA-1.92%
- 2026-09-24Meta Expands AI Hardware and Deploys Muse Enterprise AgentMETA NVDA SHOP-1.92%
- 2026-09-24Ark Invest reported to have bought Nvidia amid QQQ-fueled tech rallyNVDA QQQ+1.47%
- 2026-09-24Nvidia in focus after Ark buy and tech-led Q3 earnings upsideNVDA+2.80%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.